RecruitingNCT07204314
Vortioxetine for depression in Japanese adolescents
About this title
Read the official source — NCT07204314Medication studyAges 12–17Japan
Understand this study
Who could participate?
Listed age limits: 12 years to 17 years.
What will I do during this study?
Participation lasts about 20 weeks and includes 13 clinic visits. Depending on the assigned group, you take vortioxetine or placebo (an inactive comparison treatment) tablets once daily for 14 weeks.
- Listed locations
- Nagoya and 29 more locationsSee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Participation duration
- About 20 weeks
- Treatment duration
- 14 weeks
- Visits and schedule
- 13 clinic visits
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: October 1, 2025
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 180
- Sponsor
- Takeda
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- Japan
- Age range
- From 12 Years to 17 Years
- Official registry ID
- NCT07204314
- Official title
Show the full official title
A Randomized, Double-blind, Placebo-Controlled Phase 3 Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Once-Daily Oral Administration of Vortioxetine in Japanese Pediatric Patients 12 to 17 Years of Age With Major Depressive Disorder (MDD)
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Nagoya · Hirosaki · Chūōku
24 more locations
- Shirakawa
- Sapporo
- Zentsujichó
- Kawasaki
- Yokohama
- Nankoku
- Sendai
- Miyakonojō
- Kashihara
- Chuo-ku
- Ginowan
- Urasoe
- Ōsaka-sayama
- Koshigaya
- Fuchū
- Kodaira
- Minato-ku
- Suginome
- Toshima-ku
- Kagoshima
- Kumamoto
- Miyazaki
- Osaka
- Toyama
Interested in joining this study?
Questions about this study
What will I need to do?
You will take study medication.
Who is behind this study?
The study sponsor is Takeda.
Does this study involve medication?
Yes. The study involves medication, including Vortioxetine tablets and Placebo tablets.
Who can participate?
Listed age limits: 12 years to 17 years.
Is this study still recruiting?
The registry lists this study as recruiting.
